RT Book, Section A1 Amato, Anthony A. A1 Russell, James A. SR Print(0) ID 1115656802 T1 Principles of Immunomodulating Treatment T2 Neuromuscular Disorders, 2e YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071752503 LK neurology.mhmedical.com/content.aspx?aid=1115656802 RD 2024/10/14 AB The ideal of every patient and physician is to identify a diagnosis whose natural history is self-limited, or if not, a diagnosis for which an effective treatment can be administered. Autoimmunity is believed to be the contributing, if not causal, mechanism of a significant number of neuromuscular disorders.1 Accordingly, patients with proven or suspected autoimmune neuromuscular disorders become candidates for treatments that modulate or suppress immune-mediated nerve, neuromuscular junction, or muscle dysfunction or injury. Familiarity with drugs or other interventions that suppress or modulate the patient's immune system is therefore a prerequisite for anyone practicing neuromuscular medicine.